| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 7.73e-12 | 46 | 22 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.23e-08 | 188 | 22 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 7.60e-05 | 12 | 22 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.13e-04 | 891 | 22 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.34e-03 | 201 | 22 | 3 | GO:0061135 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 2.71e-03 | 257 | 22 | 3 | GO:0061134 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.18e-06 | 76 | 22 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.05e-05 | 377 | 22 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.10e-05 | 378 | 22 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.15e-05 | 379 | 22 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 2.48e-04 | 296 | 22 | 4 | GO:0051259 | |
| GeneOntologyCellularComponent | collagen trimer | 2.98e-12 | 88 | 22 | 7 | GO:0005581 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.53e-10 | 12 | 22 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.53e-10 | 12 | 22 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.44e-09 | 21 | 22 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.93e-07 | 530 | 22 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.24e-07 | 332 | 22 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.28e-06 | 656 | 22 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.35e-06 | 658 | 22 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen type V trimer | 6.34e-06 | 4 | 22 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | paraspeckles | 4.73e-05 | 10 | 22 | 2 | GO:0042382 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 3.47e-06 | 3 | 6 | 2 | HP:0006201 | |
| HumanPheno | Atrophic scars | 6.95e-06 | 37 | 6 | 3 | HP:0001075 | |
| HumanPheno | Hypermobility of interphalangeal joints | 1.15e-05 | 5 | 6 | 2 | HP:0005620 | |
| HumanPheno | Finger joint hypermobility | 1.96e-05 | 52 | 6 | 3 | HP:0006094 | |
| HumanPheno | Abnormality of hand joint mobility | 2.59e-05 | 57 | 6 | 3 | HP:0006256 | |
| HumanPheno | Arterial rupture | 3.23e-05 | 8 | 6 | 2 | HP:0025019 | |
| HumanPheno | Small joint hypermobilty | 4.62e-05 | 69 | 6 | 3 | HP:0430046 | |
| HumanPheno | Cigarette-paper scars | 5.18e-05 | 10 | 6 | 2 | HP:0001073 | |
| HumanPheno | Atypical scarring of skin | 5.71e-05 | 74 | 6 | 3 | HP:0000987 | |
| HumanPheno | Scarring | 1.49e-04 | 102 | 6 | 3 | HP:0100699 | |
| HumanPheno | Dermal atrophy | 1.72e-04 | 107 | 6 | 3 | HP:0004334 | |
| HumanPheno | Dermal translucency | 4.01e-04 | 27 | 6 | 2 | HP:0010648 | |
| HumanPheno | Bladder diverticulum | 7.16e-04 | 36 | 6 | 2 | HP:0000015 | |
| HumanPheno | Fragile skin | 7.56e-04 | 37 | 6 | 2 | HP:0001030 | |
| Domain | Collagen | 5.07e-12 | 85 | 22 | 7 | PF01391 | |
| Domain | Collagen | 5.07e-12 | 85 | 22 | 7 | IPR008160 | |
| Domain | Fib_collagen_C | 2.33e-07 | 11 | 22 | 3 | IPR000885 | |
| Domain | NC1_FIB | 2.33e-07 | 11 | 22 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 2.33e-07 | 11 | 22 | 3 | PD002078 | |
| Domain | COLFI | 2.33e-07 | 11 | 22 | 3 | SM00038 | |
| Domain | COLFI | 2.33e-07 | 11 | 22 | 3 | PF01410 | |
| Domain | VWA | 3.78e-05 | 56 | 22 | 3 | PF00092 | |
| Domain | - | 8.71e-05 | 74 | 22 | 3 | 3.40.50.410 | |
| Domain | RRM_1 | 9.34e-05 | 208 | 22 | 4 | PF00076 | |
| Domain | RRM | 1.10e-04 | 217 | 22 | 4 | SM00360 | |
| Domain | VWFA | 1.18e-04 | 82 | 22 | 3 | PS50234 | |
| Domain | VWA | 1.27e-04 | 84 | 22 | 3 | SM00327 | |
| Domain | RRM_dom | 1.31e-04 | 227 | 22 | 4 | IPR000504 | |
| Domain | RRM | 1.38e-04 | 230 | 22 | 4 | PS50102 | |
| Domain | - | 1.73e-04 | 244 | 22 | 4 | 3.30.70.330 | |
| Domain | - | 2.00e-04 | 18 | 22 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.00e-04 | 18 | 22 | 2 | IPR020901 | |
| Domain | KU | 2.00e-04 | 18 | 22 | 2 | SM00131 | |
| Domain | VWF_A | 2.07e-04 | 99 | 22 | 3 | IPR002035 | |
| Domain | Nucleotide-bd_a/b_plait | 2.14e-04 | 258 | 22 | 4 | IPR012677 | |
| Domain | BPTI_KUNITZ_2 | 2.24e-04 | 19 | 22 | 2 | PS50279 | |
| Domain | BPTI_KUNITZ_1 | 2.24e-04 | 19 | 22 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 2.24e-04 | 19 | 22 | 2 | PF00014 | |
| Domain | TSPN | 3.30e-04 | 23 | 22 | 2 | SM00210 | |
| Domain | Kunitz_BPTI | 3.30e-04 | 23 | 22 | 2 | IPR002223 | |
| Domain | Laminin_G | 2.10e-03 | 58 | 22 | 2 | IPR001791 | |
| Domain | ConA-like_dom | 2.71e-02 | 219 | 22 | 2 | IPR013320 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.55e-11 | 41 | 20 | 6 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.43e-11 | 44 | 20 | 6 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.89e-10 | 61 | 20 | 6 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.37e-10 | 67 | 20 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 7.33e-10 | 76 | 20 | 6 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.06e-09 | 90 | 20 | 6 | M631 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.51e-07 | 43 | 20 | 4 | M39565 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.05e-07 | 47 | 20 | 4 | MM14925 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.51e-07 | 50 | 20 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.25e-07 | 53 | 20 | 4 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.11e-06 | 258 | 20 | 6 | MM14572 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.46e-06 | 61 | 20 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.77e-06 | 64 | 20 | 4 | M26953 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.33e-06 | 19 | 20 | 3 | MM15512 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.66e-06 | 300 | 20 | 6 | M610 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.74e-06 | 20 | 20 | 3 | MM15061 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.54e-06 | 76 | 20 | 4 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.54e-06 | 76 | 20 | 4 | MM14867 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.28e-06 | 84 | 20 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.54e-06 | 85 | 20 | 4 | M16441 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.99e-06 | 27 | 20 | 3 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 7.82e-06 | 28 | 20 | 3 | MM15957 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.68e-06 | 30 | 20 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.68e-06 | 30 | 20 | 3 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.18e-05 | 32 | 20 | 3 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.78e-05 | 114 | 20 | 4 | MM14571 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.00e-05 | 38 | 20 | 3 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.52e-05 | 41 | 20 | 3 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.71e-05 | 42 | 20 | 3 | M7169 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.57e-05 | 46 | 20 | 3 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.99e-05 | 140 | 20 | 4 | M587 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.80e-05 | 57 | 20 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.17e-05 | 58 | 20 | 3 | M2049 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.55e-05 | 59 | 20 | 3 | M27218 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.19e-05 | 63 | 20 | 3 | M11187 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.06e-04 | 66 | 20 | 3 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.10e-04 | 67 | 20 | 3 | MM15345 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.48e-04 | 74 | 20 | 3 | M160 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.56e-04 | 199 | 20 | 4 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.80e-04 | 79 | 20 | 3 | M27643 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.22e-04 | 19 | 20 | 2 | M27221 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.40e-04 | 261 | 20 | 4 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 7.27e-04 | 532 | 20 | 5 | M27870 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.63e-04 | 302 | 20 | 4 | M39719 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.12e-04 | 30 | 20 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.12e-04 | 30 | 20 | 2 | MM15812 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.01e-03 | 326 | 20 | 4 | MM15917 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.03e-03 | 575 | 20 | 5 | M29853 | |
| Pathway | WP_FOCAL_ADHESION | 2.22e-03 | 187 | 20 | 3 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.53e-03 | 418 | 20 | 4 | MM15587 | |
| Pathway | WP_MRNA_PROCESSING | 3.33e-03 | 451 | 20 | 4 | MM15946 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 3.55e-03 | 63 | 20 | 2 | M8 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 4.89e-03 | 502 | 20 | 4 | MM14537 | |
| Pubmed | 1.04e-09 | 175 | 22 | 6 | 28071719 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.86e-09 | 97 | 22 | 5 | 27559042 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.04e-08 | 135 | 22 | 5 | 28675934 | |
| Pubmed | 2.63e-08 | 10 | 22 | 3 | 20864640 | ||
| Pubmed | 2.71e-08 | 50 | 22 | 4 | 23658023 | ||
| Pubmed | 5.93e-08 | 167 | 22 | 5 | 22159717 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.11e-07 | 457 | 22 | 6 | 32344865 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.31e-07 | 462 | 22 | 6 | 31138677 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 2981217 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 7825727 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.75e-07 | 254 | 22 | 5 | 28431233 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 6501291 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 34205850 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7346227 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 17662583 | ||
| Pubmed | hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. | 1.15e-06 | 3 | 22 | 2 | 19874820 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 17146610 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.15e-06 | 3 | 22 | 2 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.15e-06 | 3 | 22 | 2 | 1879336 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 24641356 | ||
| Pubmed | 1.75e-06 | 615 | 22 | 6 | 31048545 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 19932771 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 24361166 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12874293 | ||
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 2.29e-06 | 4 | 22 | 2 | 8984825 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 1409674 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 8686743 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 1916105 | ||
| Pubmed | 2.48e-06 | 153 | 22 | 4 | 25037231 | ||
| Pubmed | 2.52e-06 | 655 | 22 | 6 | 35819319 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 3.82e-06 | 5 | 22 | 2 | 14758483 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 15365990 | ||
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 3.82e-06 | 5 | 22 | 2 | 12592609 | |
| Pubmed | COL3A1, CXCL8, VCAN, THBS2, and COL1A2 are correlated with the onset of biliary atresia. | 3.82e-06 | 5 | 22 | 2 | 36930067 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 19790048 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.72e-06 | 180 | 22 | 4 | 35198878 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 8188220 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 10722718 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 5.72e-06 | 6 | 22 | 2 | 17029294 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 17135260 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 15514164 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 9101290 | ||
| Pubmed | 7.89e-06 | 205 | 22 | 4 | 27976729 | ||
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 23273220 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 8.11e-06 | 62 | 22 | 3 | 28344315 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 8.32e-06 | 807 | 22 | 6 | 22681889 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 9.63e-06 | 1284 | 22 | 7 | 17353931 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.04e-05 | 220 | 22 | 4 | 35785414 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 1.07e-05 | 8 | 22 | 2 | 33875569 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.07e-05 | 8 | 22 | 2 | 9382709 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 18816857 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 1981051 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 15872058 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 1.07e-05 | 8 | 22 | 2 | 24563484 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 1.37e-05 | 9 | 22 | 2 | 31844321 | |
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 8900172 | ||
| Pubmed | 1.71e-05 | 10 | 22 | 2 | 14559231 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 1.71e-05 | 10 | 22 | 2 | 15345741 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.95e-05 | 258 | 22 | 4 | 37794589 | |
| Pubmed | 2.09e-05 | 11 | 22 | 2 | 15121863 | ||
| Pubmed | 14-3-3sigma controls mitotic translation to facilitate cytokinesis. | 2.17e-05 | 86 | 22 | 3 | 17361185 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.17e-05 | 86 | 22 | 3 | 28327460 | |
| Pubmed | 2.37e-05 | 971 | 22 | 6 | 33306668 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 2.41e-05 | 89 | 22 | 3 | 22446626 | |
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 1358796 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 2.97e-05 | 13 | 22 | 2 | 21173153 | |
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 2.97e-05 | 13 | 22 | 2 | 20498044 | |
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 3.12e-05 | 97 | 22 | 3 | 37151849 | |
| Pubmed | 3.29e-05 | 295 | 22 | 4 | 26209609 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 28809397 | ||
| Pubmed | Loss of flow responsive Tie1 results in Impaired
Aortic valve remodeling. | 3.46e-05 | 14 | 22 | 2 | 31319059 | |
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 16236725 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 29593327 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 3.99e-05 | 15 | 22 | 2 | 9832566 | |
| Pubmed | Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs. | 3.99e-05 | 15 | 22 | 2 | 28684544 | |
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 4.14e-05 | 313 | 22 | 4 | 16196087 | |
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 4.18e-05 | 107 | 22 | 3 | 20508642 | |
| Pubmed | 4.42e-05 | 109 | 22 | 3 | 29511296 | ||
| Pubmed | 4.56e-05 | 16 | 22 | 2 | 17881772 | ||
| Pubmed | Quantitative interaction proteomics of neurodegenerative disease proteins. | 4.68e-05 | 323 | 22 | 4 | 25959826 | |
| Pubmed | 5.05e-05 | 114 | 22 | 3 | 31553912 | ||
| Pubmed | 5.33e-05 | 334 | 22 | 4 | 30425250 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.55e-05 | 678 | 22 | 5 | 30209976 | |
| Pubmed | 5.71e-05 | 340 | 22 | 4 | 24332808 | ||
| Pubmed | 5.79e-05 | 1139 | 22 | 6 | 36417873 | ||
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 11311202 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 5.81e-05 | 18 | 22 | 2 | 39040056 | |
| Pubmed | 6.18e-05 | 122 | 22 | 3 | 29530978 | ||
| Pubmed | 6.18e-05 | 347 | 22 | 4 | 16033648 | ||
| Pubmed | Muscle composition is regulated by a Lox-TGFβ feedback loop. | 6.49e-05 | 19 | 22 | 2 | 25715398 | |
| Pubmed | Pericytes are required for blood-brain barrier integrity during embryogenesis. | 6.49e-05 | 19 | 22 | 2 | 20944625 | |
| Pubmed | 6.49e-05 | 19 | 22 | 2 | 23912999 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 6.63e-05 | 704 | 22 | 5 | 32994395 | |
| Pubmed | 7.04e-05 | 713 | 22 | 5 | 29802200 | ||
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 7.46e-05 | 130 | 22 | 3 | 32905556 | |
| Pubmed | Partners of wild type Grb7 and a mutant lacking its calmodulin-binding domain. | 7.96e-05 | 21 | 22 | 2 | 32360748 | |
| Pubmed | 8.53e-05 | 136 | 22 | 3 | 21280222 | ||
| Pubmed | TOPORS functions as a SUMO-1 E3 ligase for chromatin-modifying proteins. | 8.76e-05 | 22 | 22 | 2 | 17803295 | |
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 27527664 | ||
| Pubmed | 8.76e-05 | 22 | 22 | 2 | 25516967 | ||
| Interaction | MIR19B1 interactions | 8.16e-08 | 104 | 22 | 5 | int:MIR19B1 | |
| Interaction | MIR34B interactions | 1.08e-07 | 110 | 22 | 5 | int:MIR34B | |
| Interaction | MIR29B1 interactions | 1.10e-06 | 73 | 22 | 4 | int:MIR29B1 | |
| Interaction | MIR429 interactions | 1.30e-06 | 76 | 22 | 4 | int:MIR429 | |
| Interaction | MIR200A interactions | 1.37e-06 | 77 | 22 | 4 | int:MIR200A | |
| Interaction | MIR31 interactions | 1.94e-06 | 84 | 22 | 4 | int:MIR31 | |
| Interaction | MIR17 interactions | 2.03e-06 | 85 | 22 | 4 | int:MIR17 | |
| Interaction | MIR93 interactions | 2.03e-06 | 85 | 22 | 4 | int:MIR93 | |
| Interaction | MIR20B interactions | 2.13e-06 | 86 | 22 | 4 | int:MIR20B | |
| Interaction | CYLD interactions | 2.14e-06 | 868 | 22 | 8 | int:CYLD | |
| Interaction | MIR141 interactions | 2.34e-06 | 88 | 22 | 4 | int:MIR141 | |
| Interaction | MIR29C interactions | 2.45e-06 | 89 | 22 | 4 | int:MIR29C | |
| Interaction | MIR221 interactions | 2.56e-06 | 90 | 22 | 4 | int:MIR221 | |
| Interaction | MIRLET7F1 interactions | 3.04e-06 | 94 | 22 | 4 | int:MIRLET7F1 | |
| Interaction | MIR21 interactions | 3.45e-06 | 97 | 22 | 4 | int:MIR21 | |
| Interaction | MIR363 interactions | 3.45e-06 | 97 | 22 | 4 | int:MIR363 | |
| Interaction | MIR128-2 interactions | 3.74e-06 | 99 | 22 | 4 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 3.90e-06 | 100 | 22 | 4 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 4.06e-06 | 101 | 22 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 4.06e-06 | 101 | 22 | 4 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 4.06e-06 | 101 | 22 | 4 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 4.22e-06 | 102 | 22 | 4 | int:MIRLET7A3 | |
| Interaction | MIR34A interactions | 4.56e-06 | 104 | 22 | 4 | int:MIR34A | |
| Interaction | NUP35 interactions | 4.69e-06 | 424 | 22 | 6 | int:NUP35 | |
| Interaction | MIRLET7E interactions | 4.92e-06 | 106 | 22 | 4 | int:MIRLET7E | |
| Interaction | MIRLET7I interactions | 6.57e-06 | 114 | 22 | 4 | int:MIRLET7I | |
| Interaction | MIRLET7G interactions | 7.28e-06 | 117 | 22 | 4 | int:MIRLET7G | |
| Interaction | COL5A3 interactions | 5.09e-05 | 10 | 22 | 2 | int:COL5A3 | |
| Interaction | MIR29B2 interactions | 6.15e-05 | 71 | 22 | 3 | int:MIR29B2 | |
| Interaction | MIR140 interactions | 6.15e-05 | 71 | 22 | 3 | int:MIR140 | |
| Interaction | MIR18A interactions | 6.68e-05 | 73 | 22 | 3 | int:MIR18A | |
| Interaction | MIR20A interactions | 6.96e-05 | 74 | 22 | 3 | int:MIR20A | |
| Interaction | MIR15A interactions | 7.25e-05 | 75 | 22 | 3 | int:MIR15A | |
| Interaction | RNF113A interactions | 7.47e-05 | 692 | 22 | 6 | int:RNF113A | |
| Interaction | MIR16-1 interactions | 7.54e-05 | 76 | 22 | 3 | int:MIR16-1 | |
| Interaction | MIR7-3 interactions | 7.54e-05 | 76 | 22 | 3 | int:MIR7-3 | |
| Interaction | MIR9-2 interactions | 7.84e-05 | 77 | 22 | 3 | int:MIR9-2 | |
| Interaction | COL1A2 interactions | 8.15e-05 | 78 | 22 | 3 | int:COL1A2 | |
| Interaction | MIR92A1 interactions | 8.15e-05 | 78 | 22 | 3 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 8.15e-05 | 78 | 22 | 3 | int:MIR98 | |
| Interaction | MIR222 interactions | 8.46e-05 | 79 | 22 | 3 | int:MIR222 | |
| Interaction | MIR206 interactions | 8.46e-05 | 79 | 22 | 3 | int:MIR206 | |
| Interaction | MIR145 interactions | 9.12e-05 | 81 | 22 | 3 | int:MIR145 | |
| Interaction | MIR10B interactions | 9.46e-05 | 82 | 22 | 3 | int:MIR10B | |
| Interaction | MIR106A interactions | 9.80e-05 | 83 | 22 | 3 | int:MIR106A | |
| Interaction | MIR200B interactions | 1.02e-04 | 84 | 22 | 3 | int:MIR200B | |
| Interaction | MIR7-2 interactions | 1.02e-04 | 84 | 22 | 3 | int:MIR7-2 | |
| Interaction | MIR16-2 interactions | 1.05e-04 | 85 | 22 | 3 | int:MIR16-2 | |
| Interaction | MIR107 interactions | 1.05e-04 | 85 | 22 | 3 | int:MIR107 | |
| Interaction | MIR9-1 interactions | 1.05e-04 | 85 | 22 | 3 | int:MIR9-1 | |
| Interaction | MIR138-2 interactions | 1.17e-04 | 88 | 22 | 3 | int:MIR138-2 | |
| Interaction | MIR92A2 interactions | 1.25e-04 | 90 | 22 | 3 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 1.25e-04 | 90 | 22 | 3 | int:MIR1-1 | |
| Interaction | EYA4 interactions | 1.27e-04 | 243 | 22 | 4 | int:EYA4 | |
| Interaction | MIR200C interactions | 1.29e-04 | 91 | 22 | 3 | int:MIR200C | |
| Interaction | MIR155 interactions | 1.33e-04 | 92 | 22 | 3 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 1.33e-04 | 92 | 22 | 3 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 1.37e-04 | 93 | 22 | 3 | int:MIR214 | |
| Interaction | MIR205 interactions | 1.37e-04 | 93 | 22 | 3 | int:MIR205 | |
| Interaction | MIR19B2 interactions | 1.42e-04 | 94 | 22 | 3 | int:MIR19B2 | |
| Interaction | NANOG interactions | 1.43e-04 | 481 | 22 | 5 | int:NANOG | |
| Interaction | MIRLET7A2 interactions | 1.51e-04 | 96 | 22 | 3 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 1.56e-04 | 97 | 22 | 3 | int:MIRLET7C | |
| Interaction | MIRLET7F2 interactions | 1.56e-04 | 97 | 22 | 3 | int:MIRLET7F2 | |
| Interaction | MIR106B interactions | 1.61e-04 | 98 | 22 | 3 | int:MIR106B | |
| Interaction | MIR15B interactions | 1.86e-04 | 103 | 22 | 3 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 1.86e-04 | 103 | 22 | 3 | int:MIR7-1 | |
| Interaction | PSMB8 interactions | 1.97e-04 | 105 | 22 | 3 | int:PSMB8 | |
| Interaction | REST interactions | 2.02e-04 | 274 | 22 | 4 | int:REST | |
| Interaction | MIRLET7A1 interactions | 2.14e-04 | 108 | 22 | 3 | int:MIRLET7A1 | |
| Interaction | WWP2 interactions | 2.16e-04 | 840 | 22 | 6 | int:WWP2 | |
| Interaction | CELF1 interactions | 2.44e-04 | 288 | 22 | 4 | int:CELF1 | |
| Interaction | EIF3F interactions | 2.71e-04 | 296 | 22 | 4 | int:EIF3F | |
| Interaction | MTMR8 interactions | 3.36e-04 | 25 | 22 | 2 | int:MTMR8 | |
| Interaction | DTX2 interactions | 4.09e-04 | 330 | 22 | 4 | int:DTX2 | |
| Interaction | AHNAK2 interactions | 5.08e-04 | 145 | 22 | 3 | int:AHNAK2 | |
| Interaction | AR interactions | 5.30e-04 | 992 | 22 | 6 | int:AR | |
| Interaction | PDGFA interactions | 5.53e-04 | 32 | 22 | 2 | int:PDGFA | |
| Interaction | VWF interactions | 5.53e-04 | 32 | 22 | 2 | int:VWF | |
| Interaction | MYEF2 interactions | 5.83e-04 | 152 | 22 | 3 | int:MYEF2 | |
| Interaction | MDM2 interactions | 6.06e-04 | 658 | 22 | 5 | int:MDM2 | |
| Interaction | MEN1 interactions | 6.43e-04 | 1029 | 22 | 6 | int:MEN1 | |
| Interaction | RC3H2 interactions | 6.45e-04 | 667 | 22 | 5 | int:RC3H2 | |
| Interaction | ITGB3 interactions | 8.07e-04 | 170 | 22 | 3 | int:ITGB3 | |
| Interaction | COL3A1 interactions | 8.23e-04 | 39 | 22 | 2 | int:COL3A1 | |
| Interaction | LINC00624 interactions | 8.23e-04 | 39 | 22 | 2 | int:LINC00624 | |
| Interaction | EXOSC2 interactions | 9.52e-04 | 180 | 22 | 3 | int:EXOSC2 | |
| Interaction | VTN interactions | 9.99e-04 | 183 | 22 | 3 | int:VTN | |
| Interaction | FXR2 interactions | 1.10e-03 | 430 | 22 | 4 | int:FXR2 | |
| Interaction | EIF4G1 interactions | 1.13e-03 | 433 | 22 | 4 | int:EIF4G1 | |
| Interaction | MYOC interactions | 1.24e-03 | 48 | 22 | 2 | int:MYOC | |
| Interaction | TADA2A interactions | 1.25e-03 | 198 | 22 | 3 | int:TADA2A | |
| Interaction | FZR1 interactions | 1.27e-03 | 1172 | 22 | 6 | int:FZR1 | |
| Interaction | LAIR2 interactions | 1.30e-03 | 49 | 22 | 2 | int:LAIR2 | |
| Interaction | PAX3 interactions | 1.46e-03 | 52 | 22 | 2 | int:PAX3 | |
| Interaction | TIMM9 interactions | 1.46e-03 | 52 | 22 | 2 | int:TIMM9 | |
| Interaction | PRMT5 interactions | 1.54e-03 | 471 | 22 | 4 | int:PRMT5 | |
| Interaction | CAPN1 interactions | 1.59e-03 | 215 | 22 | 3 | int:CAPN1 | |
| Interaction | SSR4 interactions | 1.61e-03 | 216 | 22 | 3 | int:SSR4 | |
| Interaction | ARHGAP24 interactions | 1.73e-03 | 486 | 22 | 4 | int:ARHGAP24 | |
| Cytoband | 14q24.3 | 9.13e-04 | 93 | 22 | 2 | 14q24.3 | |
| GeneFamily | Collagens | 3.51e-12 | 46 | 18 | 6 | 490 | |
| GeneFamily | RNA binding motif containing | 5.03e-05 | 213 | 18 | 4 | 725 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.37e-02 | 181 | 18 | 2 | 694 | |
| Coexpression | NABA_COLLAGENS | 9.91e-13 | 43 | 22 | 6 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.15e-12 | 44 | 22 | 6 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | 7.34e-08 | 270 | 22 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 8.18e-08 | 275 | 22 | 6 | M5884 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 6.76e-07 | 21 | 22 | 3 | M4767 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.30e-06 | 35 | 22 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.60e-06 | 36 | 22 | 3 | MM1212 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 1.15e-05 | 644 | 22 | 6 | M41717 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.24e-05 | 54 | 22 | 3 | M4737 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 2.07e-05 | 64 | 22 | 3 | M2572 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.16e-05 | 200 | 22 | 4 | M5930 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 2.17e-05 | 65 | 22 | 3 | M39309 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.59e-05 | 69 | 22 | 3 | M10165 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 3.20e-05 | 74 | 22 | 3 | M13547 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.68e-05 | 11 | 22 | 2 | M47997 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.89e-05 | 79 | 22 | 3 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 4.04e-05 | 80 | 22 | 3 | MM1285 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 4.20e-05 | 81 | 22 | 3 | M39253 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 5.94e-05 | 91 | 22 | 3 | M40180 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 6.34e-05 | 93 | 22 | 3 | M4752 | |
| Coexpression | KAYO_CALORIE_RESTRICTION_MUSCLE_UP | 6.55e-05 | 94 | 22 | 3 | M7013 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.76e-05 | 268 | 22 | 4 | M45796 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 7.19e-05 | 97 | 22 | 3 | M45794 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 8.46e-05 | 284 | 22 | 4 | M16975 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.14e-04 | 19 | 22 | 2 | M15125 | |
| Coexpression | NABA_MATRISOME | 1.40e-04 | 1008 | 22 | 6 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.54e-04 | 1026 | 22 | 6 | M5889 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.00e-04 | 137 | 22 | 3 | M40313 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 2.31e-04 | 369 | 22 | 4 | MM16610 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 2.32e-04 | 144 | 22 | 3 | M1484 | |
| Coexpression | WESTON_VEGFA_TARGETS_12HR | 2.33e-04 | 27 | 22 | 2 | M1545 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.41e-04 | 146 | 22 | 3 | M40222 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 2.51e-04 | 148 | 22 | 3 | MM1010 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 2.59e-04 | 380 | 22 | 4 | M41703 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 2.69e-04 | 29 | 22 | 2 | M7581 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_DN | 3.08e-04 | 31 | 22 | 2 | M18395 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 3.29e-04 | 32 | 22 | 2 | MM1307 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 3.29e-04 | 32 | 22 | 2 | MM668 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 3.29e-04 | 32 | 22 | 2 | M1558 | |
| Coexpression | BILANGES_SERUM_SENSITIVE_VIA_TSC2 | 3.29e-04 | 32 | 22 | 2 | M2334 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 3.69e-04 | 767 | 22 | 5 | M39209 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN | 3.77e-04 | 170 | 22 | 3 | M8689 | |
| Coexpression | ONDER_CDH1_TARGETS_1_DN | 3.77e-04 | 170 | 22 | 3 | M6822 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.93e-04 | 35 | 22 | 2 | MM17054 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 4.38e-04 | 179 | 22 | 3 | M41745 | |
| Coexpression | IL21_UP.V1_UP | 4.90e-04 | 186 | 22 | 3 | M2827 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 5.15e-04 | 40 | 22 | 2 | M1574 | |
| Coexpression | GSE13411_NAIVE_VS_MEMORY_BCELL_UP | 5.38e-04 | 192 | 22 | 3 | M3245 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 5.54e-04 | 194 | 22 | 3 | M39122 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP | 5.88e-04 | 198 | 22 | 3 | M9924 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN | 5.97e-04 | 199 | 22 | 3 | M9970 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 5.97e-04 | 199 | 22 | 3 | M3440 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN | 6.06e-04 | 200 | 22 | 3 | M5582 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN | 6.06e-04 | 200 | 22 | 3 | M9385 | |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP | 6.06e-04 | 200 | 22 | 3 | M9762 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 6.06e-04 | 200 | 22 | 3 | M6263 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 6.06e-04 | 200 | 22 | 3 | M5777 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 6.06e-04 | 200 | 22 | 3 | M5779 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 6.06e-04 | 200 | 22 | 3 | M6014 | |
| Coexpression | JONES_OVARY_THECA | 6.81e-04 | 46 | 22 | 2 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 6.81e-04 | 46 | 22 | 2 | MM670 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.11e-04 | 47 | 22 | 2 | M7585 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 7.41e-04 | 48 | 22 | 2 | M39318 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.56e-04 | 505 | 22 | 4 | M39167 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_UP | 8.04e-04 | 50 | 22 | 2 | M10372 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 8.04e-04 | 50 | 22 | 2 | M7337 | |
| Coexpression | WESTON_VEGFA_TARGETS_6HR | 8.04e-04 | 50 | 22 | 2 | M1521 | |
| Coexpression | DESCARTES_FETAL_STOMACH_STROMAL_CELLS | 8.04e-04 | 50 | 22 | 2 | M40304 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 8.04e-04 | 50 | 22 | 2 | MM403 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 8.39e-04 | 1407 | 22 | 6 | M14427 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 8.41e-04 | 224 | 22 | 3 | M9893 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 8.97e-04 | 229 | 22 | 3 | MM16607 | |
| Coexpression | CROONQUIST_STROMAL_STIMULATION_UP | 1.01e-03 | 56 | 22 | 2 | M5929 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.08e-03 | 58 | 22 | 2 | M178 | |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 1.16e-03 | 60 | 22 | 2 | M1515 | |
| Coexpression | DANG_REGULATED_BY_MYC_DN | 1.17e-03 | 251 | 22 | 3 | M2310 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 1.19e-03 | 61 | 22 | 2 | M8510 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.25e-03 | 257 | 22 | 3 | M13867 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.31e-03 | 261 | 22 | 3 | M1834 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 1.44e-03 | 67 | 22 | 2 | M40194 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL | 1.47e-03 | 272 | 22 | 3 | M41669 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.48e-03 | 68 | 22 | 2 | MM803 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.52e-03 | 69 | 22 | 2 | M19523 | |
| Coexpression | RHODES_UNDIFFERENTIATED_CANCER | 1.52e-03 | 69 | 22 | 2 | M8365 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 1.66e-03 | 72 | 22 | 2 | M45791 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.66e-03 | 72 | 22 | 2 | M9908 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.75e-03 | 289 | 22 | 3 | M41750 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.75e-03 | 74 | 22 | 2 | M4479 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.80e-03 | 75 | 22 | 2 | MM1084 | |
| Coexpression | HELLER_HDAC_TARGETS_DN | 1.82e-03 | 293 | 22 | 3 | M6890 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.87e-03 | 296 | 22 | 3 | M41675 | |
| Coexpression | CARD_MIR302A_TARGETS | 1.89e-03 | 77 | 22 | 2 | M2208 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 1.95e-03 | 300 | 22 | 3 | M41708 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 2.02e-03 | 304 | 22 | 3 | M39208 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 2.10e-03 | 1129 | 22 | 5 | M42508 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 2.14e-03 | 310 | 22 | 3 | MM16608 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 2.14e-03 | 82 | 22 | 2 | M39274 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 2.16e-03 | 311 | 22 | 3 | M40024 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_DN | 2.21e-03 | 314 | 22 | 3 | M14279 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 2.22e-03 | 1144 | 22 | 5 | MM3843 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 3.05e-06 | 99 | 22 | 4 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 4.04e-05 | 65 | 22 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | BM Top 100 - cervix | 4.23e-05 | 66 | 22 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - endometrium | 4.23e-05 | 66 | 22 | 3 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 4.63e-05 | 68 | 22 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 4.84e-05 | 69 | 22 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - ovary | 5.05e-05 | 70 | 22 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 5.05e-05 | 70 | 22 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 5.27e-05 | 71 | 22 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - dorsal root ganglia | 5.27e-05 | 71 | 22 | 3 | BM Top 100 - dorsal root ganglia | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 5.49e-05 | 206 | 22 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 5.50e-05 | 72 | 22 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 5.50e-05 | 72 | 22 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 5.73e-05 | 73 | 22 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 5.97e-05 | 74 | 22 | 3 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 5.97e-05 | 74 | 22 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 6.21e-05 | 75 | 22 | 3 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | BM Top 100 - vagina | 6.46e-05 | 76 | 22 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - urethra | 6.72e-05 | 77 | 22 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | BM Top 100 - vulva | 8.11e-05 | 82 | 22 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 8.71e-05 | 84 | 22 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 9.02e-05 | 85 | 22 | 3 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 9.67e-05 | 87 | 22 | 3 | GSM777050_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.26e-04 | 95 | 22 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.34e-04 | 97 | 22 | 3 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.34e-04 | 97 | 22 | 3 | GSM777046_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 1.38e-04 | 98 | 22 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.79e-04 | 107 | 22 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.63e-04 | 122 | 22 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 3.17e-04 | 130 | 22 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 3.71e-04 | 978 | 22 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.41e-04 | 156 | 22 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 6.36e-04 | 165 | 22 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.71e-04 | 168 | 22 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 8.46e-04 | 182 | 22 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.73e-04 | 191 | 22 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.20e-03 | 464 | 22 | 4 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 1.46e-03 | 489 | 22 | 4 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 1.51e-03 | 493 | 22 | 4 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 1.52e-03 | 494 | 22 | 4 | JC_fibro_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 1.54e-03 | 496 | 22 | 4 | Arv_EB-LF_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.64e-03 | 229 | 22 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.93e-03 | 63 | 22 | 2 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.11e-03 | 66 | 22 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - lymph nodes | 2.24e-03 | 68 | 22 | 2 | BM Top 100 - lymph nodes | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.48e-03 | 265 | 22 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.93e-03 | 281 | 22 | 3 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.93e-03 | 281 | 22 | 3 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 3.01e-03 | 994 | 22 | 5 | PCBC_EB_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 3.02e-03 | 284 | 22 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.20e-03 | 1479 | 22 | 6 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.20e-03 | 290 | 22 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 3.24e-03 | 82 | 22 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.55e-03 | 86 | 22 | 2 | GSM777055_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.86e-03 | 310 | 22 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | smooth muscle | 3.88e-03 | 90 | 22 | 2 | smooth muscle | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#3 | 3.97e-03 | 91 | 22 | 2 | Arv_EB-LF_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.60e-03 | 330 | 22 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_100 | 4.68e-03 | 99 | 22 | 2 | PCBC_ctl_BronchSmoothMuscl_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_100 | 4.68e-03 | 99 | 22 | 2 | JC_fibro_100 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100 | 4.77e-03 | 100 | 22 | 2 | PCBC_ratio_EB_vs_SC_100 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 15-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 4.77e-03 | 100 | 22 | 2 | PCBC_ratio_MESO-15_from-OSK-L-l-p53KD_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_episomal_vs_Mesoderm Day 15-method_NA-Confounder_removed-fold2.0_adjp0.05 | 4.77e-03 | 100 | 22 | 2 | PCBC_ratio_MESO-15_from-episomal_vs_MESO-15_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.84e-03 | 336 | 22 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.88e-03 | 337 | 22 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-10 | 200 | 22 | 6 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-10 | 200 | 22 | 6 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-08 | 185 | 22 | 5 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-08 | 192 | 22 | 5 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.33e-08 | 192 | 22 | 5 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-08 | 199 | 22 | 5 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.97e-07 | 153 | 22 | 4 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.97e-07 | 153 | 22 | 4 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.97e-07 | 153 | 22 | 4 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.94e-07 | 157 | 22 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 159 | 22 | 4 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.05e-06 | 159 | 22 | 4 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 159 | 22 | 4 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 165 | 22 | 4 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 167 | 22 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 167 | 22 | 4 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-06 | 167 | 22 | 4 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 169 | 22 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 169 | 22 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-06 | 169 | 22 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-06 | 169 | 22 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 170 | 22 | 4 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-06 | 171 | 22 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-06 | 174 | 22 | 4 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 1.50e-06 | 174 | 22 | 4 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 176 | 22 | 4 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-06 | 176 | 22 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 176 | 22 | 4 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-06 | 176 | 22 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 180 | 22 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 180 | 22 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 180 | 22 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-06 | 180 | 22 | 4 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-06 | 181 | 22 | 4 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-06 | 181 | 22 | 4 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.75e-06 | 181 | 22 | 4 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-06 | 181 | 22 | 4 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.79e-06 | 182 | 22 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-06 | 182 | 22 | 4 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 182 | 22 | 4 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-06 | 182 | 22 | 4 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.83e-06 | 183 | 22 | 4 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-06 | 183 | 22 | 4 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 183 | 22 | 4 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 183 | 22 | 4 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-06 | 183 | 22 | 4 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 183 | 22 | 4 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-06 | 183 | 22 | 4 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 184 | 22 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-06 | 184 | 22 | 4 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-06 | 184 | 22 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-06 | 184 | 22 | 4 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 1.87e-06 | 184 | 22 | 4 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-06 | 185 | 22 | 4 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 185 | 22 | 4 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 185 | 22 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.95e-06 | 186 | 22 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-06 | 186 | 22 | 4 | 827f2f2ddde315d1e5970dd56f906c555ec699af | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 186 | 22 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.95e-06 | 186 | 22 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-06 | 187 | 22 | 4 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 188 | 22 | 4 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 188 | 22 | 4 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-06 | 188 | 22 | 4 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 188 | 22 | 4 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-06 | 189 | 22 | 4 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 189 | 22 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 189 | 22 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-06 | 190 | 22 | 4 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-06 | 190 | 22 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Limb_Muscle|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | 06c2b13fa88abbcb8086f13b8d98a156e41e4198 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 190 | 22 | 4 | 2abeb013bb83c578e67dcb985ba44ca63134950b | |
| ToppCell | droplet-Mammary_Gland-nan-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 191 | 22 | 4 | 8022059e434fd411dc539819f969bd4f94861281 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 191 | 22 | 4 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | facs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 191 | 22 | 4 | 6242f83acaf1714e9c1771a832cb67674b19e96d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-06 | 191 | 22 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-06 | 191 | 22 | 4 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 191 | 22 | 4 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-06 | 191 | 22 | 4 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.33e-05 | 50 | 14 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.33e-05 | 50 | 14 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of CDH11 | 4.65e-04 | 25 | 14 | 2 | GNF2_CDH11 | |
| Computational | Neighborhood of TDG | 9.15e-04 | 35 | 14 | 2 | GNF2_TDG | |
| Computational | Neighborhood of PTX3 | 9.68e-04 | 36 | 14 | 2 | GNF2_PTX3 | |
| Computational | Neighborhood of RAD21 | 1.02e-03 | 37 | 14 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of ELAC2 | 1.58e-03 | 46 | 14 | 2 | GNF2_ELAC2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Neighborhood of PPP1CC | 2.33e-03 | 56 | 14 | 2 | GCM_PPP1CC | |
| Computational | Neighborhood of DEK | 2.50e-03 | 58 | 14 | 2 | GNF2_DEK | |
| Computational | ECM and collagens. | 2.78e-03 | 225 | 14 | 3 | MODULE_47 | |
| Computational | Neighborhood of SMC1L1 | 2.85e-03 | 62 | 14 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of DDX5 | 3.13e-03 | 65 | 14 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of KPNB1 | 3.93e-03 | 73 | 14 | 2 | GNF2_KPNB1 | |
| Computational | Neighborhood of XRCC5 | 4.14e-03 | 75 | 14 | 2 | GNF2_XRCC5 | |
| Drug | AC1LAKND | 3.23e-09 | 62 | 22 | 5 | CID000470146 | |
| Drug | GK-101 | 3.77e-08 | 36 | 22 | 4 | CID000161853 | |
| Drug | Madecassol | 1.04e-07 | 46 | 22 | 4 | CID000108062 | |
| Drug | d-indobufen | 1.46e-07 | 50 | 22 | 4 | CID000044562 | |
| Drug | DMSe | 1.48e-07 | 132 | 22 | 5 | CID000020796 | |
| Drug | ridogrel | 1.72e-07 | 52 | 22 | 4 | CID005362391 | |
| Drug | NSC49633 | 1.86e-07 | 53 | 22 | 4 | CID000023340 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 4.09e-07 | 162 | 22 | 5 | CID000072363 | |
| Drug | khellin | 5.35e-07 | 171 | 22 | 5 | CID000003828 | |
| Drug | BAPN | 6.09e-07 | 71 | 22 | 4 | CID000001647 | |
| Drug | malotilate | 6.09e-07 | 71 | 22 | 4 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 6.81e-07 | 73 | 22 | 4 | CID000094284 | |
| Drug | AC1NMZ1B | 7.59e-07 | 75 | 22 | 4 | CID005034185 | |
| Drug | strontium ranelate | 8.44e-07 | 77 | 22 | 4 | CID006918182 | |
| Drug | foscarnet | 9.01e-07 | 190 | 22 | 5 | CID000003414 | |
| Drug | halofuginone lactate | 1.26e-06 | 85 | 22 | 4 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.65e-06 | 91 | 22 | 4 | CID000000825 | |
| Drug | ticlopidine | 2.71e-06 | 103 | 22 | 4 | CID000005472 | |
| Drug | hydroxylysine | 3.40e-06 | 109 | 22 | 4 | CID000001029 | |
| Drug | AC1L1C2F | 3.53e-06 | 110 | 22 | 4 | CID000001711 | |
| Drug | PPACK | 3.93e-06 | 113 | 22 | 4 | CID003036757 | |
| Drug | AC1L9732 | 4.07e-06 | 114 | 22 | 4 | CID000439300 | |
| Drug | isodesmosine | 4.19e-06 | 33 | 22 | 3 | CID000013811 | |
| Drug | Tranilast sodium | 4.21e-06 | 115 | 22 | 4 | CID000005527 | |
| Drug | Collagenase | 5.34e-06 | 4 | 22 | 2 | DB00048 | |
| Drug | Selara | 5.87e-06 | 125 | 22 | 4 | CID000150310 | |
| Drug | pirfenidone | 8.68e-06 | 138 | 22 | 4 | CID000040632 | |
| Drug | DL-penicillamine | 8.93e-06 | 139 | 22 | 4 | CID000004727 | |
| Drug | PCR 4099 | 8.93e-06 | 139 | 22 | 4 | CID000002806 | |
| Drug | candesartan cilexetil | 1.06e-05 | 145 | 22 | 4 | CID000002540 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.33e-05 | 6 | 22 | 2 | ctd:C502971 | |
| Drug | Diphosphonates | 1.33e-05 | 6 | 22 | 2 | ctd:D004164 | |
| Drug | desmosine | 1.78e-05 | 53 | 22 | 3 | CID000025435 | |
| Drug | neo-gambogic acid | 1.87e-05 | 7 | 22 | 2 | ctd:C045863 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.02e-05 | 171 | 22 | 4 | 3297_UP | |
| Drug | 1h00 | 2.10e-05 | 56 | 22 | 3 | CID000445950 | |
| Drug | AC1L1DD6 | 2.42e-05 | 179 | 22 | 4 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.99e-05 | 189 | 22 | 4 | CID000001413 | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.31e-05 | 194 | 22 | 4 | 5952_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 3.38e-05 | 195 | 22 | 4 | 419_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.52e-05 | 197 | 22 | 4 | 3621_UP | |
| Drug | celecoxib; Down 200; 10uM; PC3; HG-U133A | 3.52e-05 | 197 | 22 | 4 | 482_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 4392_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; PC3; HG-U133A | 3.66e-05 | 199 | 22 | 4 | 457_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.73e-05 | 200 | 22 | 4 | 3822_DN | |
| Drug | chondroitin sulfate | 3.91e-05 | 413 | 22 | 5 | CID000024766 | |
| Drug | AC1Q6PCP | 6.43e-05 | 230 | 22 | 4 | CID000005267 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 8.71e-05 | 90 | 22 | 3 | CID015942693 | |
| Drug | prostacyclin sodium salt | 8.88e-05 | 250 | 22 | 4 | CID000000159 | |
| Drug | ascorbate-2-phosphate | 9.29e-05 | 15 | 22 | 2 | ctd:C011669 | |
| Drug | hyaluronan | 1.08e-04 | 263 | 22 | 4 | CID000024759 | |
| Drug | silibinin | 1.47e-04 | 285 | 22 | 4 | CID000005213 | |
| Drug | protocatechuic acid | 1.99e-04 | 119 | 22 | 3 | CID000000072 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 2.13e-04 | 314 | 22 | 4 | CID000447989 | |
| Drug | AC1L18QD | 2.43e-04 | 325 | 22 | 4 | CID000000213 | |
| Drug | losartan | 4.32e-04 | 378 | 22 | 4 | CID000003961 | |
| Drug | colchine | 4.54e-04 | 383 | 22 | 4 | CID000002833 | |
| Drug | Perindopril | 5.20e-04 | 35 | 22 | 2 | ctd:D020913 | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 5.29e-04 | 166 | 22 | 3 | 3283_UP | |
| Drug | AC1L3XKP | 5.82e-04 | 37 | 22 | 2 | CID000123931 | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 6.81e-04 | 181 | 22 | 3 | 3106_DN | |
| Drug | Y-27632 | 7.90e-04 | 444 | 22 | 4 | CID000005711 | |
| Drug | Orlistat; Up 200; 10uM; PC3; HT_HG-U133A | 8.08e-04 | 192 | 22 | 3 | 6388_UP | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 8.08e-04 | 192 | 22 | 3 | 2383_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 3608_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 2258_UP | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 7493_UP | |
| Drug | LY-171,883; Down 200; 1uM; MCF7; HG-U133A | 8.32e-04 | 194 | 22 | 3 | 222_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 2262_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 3604_UP | |
| Drug | U0125; Up 200; 1uM; PC3; HG-U133A | 8.58e-04 | 196 | 22 | 3 | 663_UP | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HG-U133A | 8.70e-04 | 197 | 22 | 3 | 224_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5207_UP | |
| Drug | SC-58125; Down 200; 10uM; MCF7; HG-U133A | 8.70e-04 | 197 | 22 | 3 | 208_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 7142_UP | |
| Drug | sulfasalazine; Up 200; 100uM; MCF7; HG-U133A | 8.70e-04 | 197 | 22 | 3 | 204_UP | |
| Drug | rapamycin; Down 200; 0.1uM; HL60; HG-U133A | 8.70e-04 | 197 | 22 | 3 | 362_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HG-U133A | 8.70e-04 | 197 | 22 | 3 | 1903_DN | |
| Drug | 17-AAG; Down 200; 0.1uM; MCF7; HG-U133A | 8.83e-04 | 198 | 22 | 3 | 221_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4757_DN | |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 1157_UP | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HG-U133A | 8.83e-04 | 198 | 22 | 3 | 1910_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 3905_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; HL60; HG-U133A | 8.83e-04 | 198 | 22 | 3 | 1775_UP | |
| Drug | MK-886; Up 200; 1uM; MCF7; HG-U133A | 8.83e-04 | 198 | 22 | 3 | 601_UP | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4235_UP | |
| Drug | Graveoline [485-61-0]; Up 200; 14.4uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2179_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 5061_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 5604_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4774_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4562_DN | |
| Drug | Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 3552_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 5459_UP | |
| Drug | TTNPB; Down 200; 0.1uM; MCF7; HG-U133A | 8.96e-04 | 199 | 22 | 3 | 223_DN | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; PC3; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 4534_UP | |
| Drug | indomethacin, USP; Up 200; 100uM; MCF7; HG-U133A | 9.09e-04 | 200 | 22 | 3 | 453_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 6023_UP | |
| Drug | benz(a)anthracene | 9.47e-04 | 1251 | 22 | 6 | ctd:C030935 | |
| Disease | Ehlers-Danlos Syndrome | 5.30e-06 | 5 | 22 | 2 | C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.90e-05 | 9 | 22 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.49e-05 | 12 | 22 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 5 measurement | 1.10e-04 | 21 | 22 | 2 | EFO_0008115 | |
| Disease | response to interferon | 1.58e-04 | 25 | 22 | 2 | EFO_0007859 | |
| Disease | Cirrhosis | 6.36e-04 | 50 | 22 | 2 | C1623038 | |
| Disease | Fibrosis | 6.36e-04 | 50 | 22 | 2 | C0016059 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.15e-04 | 53 | 22 | 2 | C4707243 | |
| Disease | magnesium measurement | 1.11e-03 | 66 | 22 | 2 | EFO_0004845 | |
| Disease | Liver Cirrhosis | 2.66e-03 | 103 | 22 | 2 | C0023890 | |
| Disease | Fibrosis, Liver | 2.77e-03 | 105 | 22 | 2 | C0239946 | |
| Disease | Abortion, Tubal | 2.98e-03 | 109 | 22 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 2.98e-03 | 109 | 22 | 2 | C3830362 | |
| Disease | Miscarriage | 2.98e-03 | 109 | 22 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 2.98e-03 | 109 | 22 | 2 | C0000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLPHGLGGIGMGLGP | 296 | P52272 | |
| LGGIGMGLGPGGQPI | 301 | P52272 | |
| GQMPGSGIGTGPGVI | 376 | P78344 | |
| VGLGPGPMGLMGPRG | 86 | P08123 | |
| GPQGPMGIPGIGSQG | 441 | Q2UY09 | |
| GMQLKGPLGPGGRGP | 226 | Q9NQS1 | |
| GPGFLGGEGPMGGPQ | 581 | Q53ET0 | |
| DRGPGGPRGIVGGGM | 431 | Q9UN86 | |
| LGPMGVPGRDGVPGG | 2176 | P12111 | |
| PMGEPGRPGQGGLEG | 1516 | Q8NFW1 | |
| GVGLRGEMGPPGIPG | 1551 | Q8NFW1 | |
| VMAPGRGPERGGGGG | 101 | Q6PJG2 | |
| TPGLQGMPGERGGLG | 721 | P02461 | |
| GLGGGGGMGPREAEP | 276 | Q15768 | |
| VGEPGLLGAPGQMGP | 1366 | P25940 | |
| RLGGGMPGLGQGPPT | 6 | O00487 | |
| QLPRGLGGIGMGLGP | 326 | Q9P2K5 | |
| LGGIGMGLGPGGQPI | 331 | Q9P2K5 | |
| GGGVGPGPGAAGPML | 421 | Q6ZMQ8 | |
| MAPVGGGGRPVGGPA | 1 | Q6P4Q7 | |
| GAGPVGGQGPRGMGP | 671 | P23246 | |
| GALIGGMVGGPIGLL | 236 | P56962 | |
| PLHQGGGGPQGFMGP | 641 | Q9C0J8 | |
| AGVGGMGLLGPGGLP | 71 | P58304 | |
| PGLLRGGAGGLGIMG | 621 | Q14003 | |
| GGAGGLGIMGLPPLP | 626 | Q14003 |